US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 25.790
  • +0.520+2.06%
Close Jan 2 16:00 ET
  • 26.280
  • +0.490+1.90%
Post 17:26 ET
1.71BMarket Cap-10.00P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 575.000K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 575.000K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--

Unlock Free Earnings Estimates

Celldex Therapeutics Earnings Reports

  • Celldex Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:07 ET

  • Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 6, 2024 16:02 ET

  • Celldex Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:57 ET

  • Celldex Therapeutics | 8-K: Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 8, 2024 16:49 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data